Pioneer Pharma plans to acquire Conflux Blockchain assets to layout in the Web3 field.

[Bit推] Listed company Linghang Pharmaceutical Biotechnology Co., Ltd. (00399) announced the signing of a memorandum of understanding, planning to acquire all shares of the target company, provided that the target company completes the acquisition of assets related to the Conflux Blockchain.

The price of this acquisition will be paid in cash, company shares, or convertible bonds, with the specific amount to be determined in the formal agreement. The memorandum of understanding is valid for 12 months, during which the seller shall not negotiate or transact with other parties regarding the equity of the target company.

Navihealth hopes to expand its business into the blockchain technology field through this acquisition, achieving business diversification and seeking new profit growth points. However, the transaction will only be finalized after a formal agreement is signed, and relevant announcements will be made in a timely manner according to listing rules. Shareholders and investors should proceed with caution.

According to reports, Hong Kong stocks will be closed today for the anniversary of the establishment of the Hong Kong Special Administrative Region.